A Single Arm Phase 2 Trial of Doxorubicin Plus Zalifrelimab (Anti-Ctla-4 Antibody) and Balstilimab (Anti-Pd-1 Antibody) in Advanced/metastatic Soft Tissue Sarcomas.
Clinical cancer research an official journal of the American Association for Cancer Research(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要